Here's a roundup of top developments in the biotech space over the last 24 hours.
Stocks In Focus
Pfizer, BioNTech Seeks Emergency Use Nod For COVID-19 Vaccine For Kids 5-11 Years
Pfizer Inc(NYSE:PFE) andBioNTech SE(NASDAQ:BNTX) have submitted an FDA Emergency Use Authorization (EUA) application for a 10-µg booster dose of COVID-19 Vaccine for children 5 through 11 years of age.
The submission included data from the Phase 2/3 clinical trial in children ages 5 through 11 years who received a booster dose approximately six months after the second dose of the Pfizer-BioNTech COVID-19 Vaccine 10-µg two-dose primary series.
Molecular...
Login or create a forever free account to read this news
Sign up/Log in